GMO Quality Fund

GMO Quality Fund

GQLIX
GMO Quality FundUS flagNASDAQ
- -
USD
- -
- -
- -
- -
(- -)

Recent

price

- -

P/E

ratio

- -

div

yld

- -

ROIC.AI

No data availableFinancial data will appear here once available

Capital Structure

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Revenue

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Earnings Per Share

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Dividends Per Share

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available
Business
GMO Quality Fund (GQLIX) is a mutual fund managed by GMO, a Boston-based asset management firm founded in 1977, that seeks long-term capital appreciation by investing primarily in high-quality, undervalued equity securities of companies worldwide. The fund employs a fundamental, value-oriented investment strategy focused on businesses with sustainable competitive advantages, strong balance sheets, and attractive valuations; it allocates across market capitalizations and sectors, including consumer staples, healthcare, industrials, and information technology, while maintaining a global portfolio with emphasis on the United States, Europe, and select emerging markets. GMO Quality Fund offers institutional share classes (GQLIX) and retail variants, with services including systematic risk management, quantitative screening for quality metrics such as return on capital and earnings stability, and active portfolio construction to mitigate downside risk. Headquartered in San Francisco with key operations in Boston and London, the fund targets sophisticated investors such as institutions and high-net-worth individuals seeking defensive growth in equity markets. In recent developments, GMO announced strategic enhancements to its equity strategies in 2024, including expanded integration of climate-aware quality factors and a new partnership with leading ESG data providers to refine stock selection; additionally, the firm completed a minor reorganization of its quality-focused offerings in early 2025, bolstering team expertise through key hires in quantitative research amid rising demand for resilient portfolios.